Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
40,198,324
-
Share change
-
+640,145
-
Total reported value
-
$4,529,145,070
-
Put/Call ratio
-
42%
-
Price per share
-
$112.68
-
Number of holders
-
294
-
Value change
-
+$67,746,251
-
Number of buys
-
147
-
Number of sells
-
159
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q4 2016
As of 31 Dec 2016,
ABIOMED INC - COMMON STOCK (ABMD) was held by
294 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,198,324 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Palo Alto Investors, LLC, BlackRock Fund Advisors, Essex Woodlands Health Ventures, Inc., BlackRock Institutional Trust Company, N.A., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, and Bank of New York Mellon Corp.
This page lists
294
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.